EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

rhCC16 Suppresses Cellular Senescence and Ameliorates COPD‐Like Symptoms by Activating the AMPK/Sirt1‐PGC‐1‐α‐TFAM Pathway to Promote Mitochondrial Function

Ying-Jie Ren, Tian-Qi Sun, Yu Lu, Dan-Li Liu, Rui Gao, Ting Li, Min Guo, Qing-Hua Liu, Hai-Long Wang iD, Min Pang

Journal of Cellular and Molecular Medicine · 2025-04 · 29 (8)

DOI: 10.1111/jcmm.70566 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 21.04.2025. Verfasst von Ying-Jie Ren und 9 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Pneumoconiosis; Shanxi Province Key Laboratory of Respiratory Disease; Department of Pulmonary and Critical Care Medicine, The …. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Cellular Senescence, Sirtuin 1, Mitochondria. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanxi Province Higher Education Billion Project Science and Technology Guidance Project, the Research Project Supported by Shanxi Scholarship Council of China, the Fund Program for the Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic obstructive pulmonary disease (COPD) is a widespread lung disease marked by alveolar wall damage, leading to inflammation and fibrosis. Key risk factors include age, smoking, sex, and education, with smoking being the most crucial. These factors are globally consistent and linked with aging. Club cell secretory protein 16 (CC16), primarily secreted by non‐ciliated bronchial epithelial cells, is crucial for pulmonary health, offering anti‐inflammatory and antioxidant benefits. CC16 levels are notably reduced in COPD, suggesting its enhancement as a potential treatment. In this study, cellular senescence of BEAS‐2B cells was stimulated using cigarette smoke extract (CSE) and the function of recombinant human CC16 protein (rhCC16) in cellular senescence was assessed by detecting the levels of β‐galactosidase, p16, p21, ROS and the underlined mechanism was revealed by measuring mitochondrial biogenesis and metabolism. Additionally, COPD mice were prepared, and rhCC16's role on the cellular senescence of lung tissues was examined. Our findings showed that rhCC16 ameliorated cellular senescence in BEAS‐2B cells and lung tissues of COPD mice accompanied by lower levels of β‐galactosidase, p16, p21 and ROS. Mechanically, rhCC16 mitigated senescence via triggering PGC‐1α expression through the AMPK/SIRT1 pathway and fostering mitochondrial biogenesis and metabolism to reduce the levels of ROS. Furthermore, the results also indicated that rhCC16 exerted its effect via both integrin α4β1 and clathrin‐mediated endocytosis. Collectively, rhCC16 suppresses cellular senescence and ameliorates COPD‐like symptoms by activating the AMPK/Sirt1‐PGC‐1‐α‐TFAM pathway to foster mitochondrial function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveCellular SenescenceSirtuin 1MitochondriaPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaAMP-Activated Protein KinasesSignal TransductionUteroglobinAnimalsHumansMiceTranscription FactorsCell LineDNA-Binding ProteinsMale

Stichwörter der Autor:innen

AMPKCOPDcellular senescencemitochondrial functionrhCC16

Substanzen

Sirtuin 1Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaAMP-Activated Protein KinasesUteroglobinTranscription FactorsDNA-Binding ProteinsSCGB1A1 protein, humanSIRT1 protein, human

Autor:innen und Institutionen

  • NHC Key Laboratory of Pneumoconiosis; Shanxi Province Key Laboratory of Respiratory Disease; Department of Pulmonary and Critical Care Medicine, The First Hospital Shanxi Medical University, Taiyuan, China.
  • School of Basic Medicine, Basic Medical Science Center Shanxi Medical University, Jinzhong, China.
  • School of Pharmacy, Academy of Medical Sciences, Shanxi Medical University, Jinzhong, China.
  • Laboratory of Animal Center, Shanxi Key Laboratory of Experimental Animal Science and Animal Model of Human Disease, Shanxi Medical University, Taiyuan, China.
  • Translational Medicine Research Center, Shanxi Medical University, Taiyuan, Shanxi, China.

ORCID-Profile: Hai-Long Wang

Förderung

  • Shanxi Province Higher Education Billion Project Science and Technology Guidance Project
  • the Research Project Supported by Shanxi Scholarship Council of China
  • the Fund Program for the Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province

Zitieren

APA

Ren, Y. J., Sun, T. Q., Lu, Y., Liu, D. L., Gao, R., Li, T., Guo, M., Liu, Q. H., Wang, H. L., & Pang, M. (2025). rhCC16 Suppresses Cellular Senescence and Ameliorates COPD‐Like Symptoms by Activating the AMPK/Sirt1‐PGC‐1‐α‐TFAM Pathway to Promote Mitochondrial Function. Journal of Cellular and Molecular Medicine, 29(8). https://doi.org/10.1111/jcmm.70566

Vancouver

Ren YJ, Sun TQ, Lu Y, Liu DL, Gao R, Li T, et al. rhCC16 Suppresses Cellular Senescence and Ameliorates COPD‐Like Symptoms by Activating the AMPK/Sirt1‐PGC‐1‐α‐TFAM Pathway to Promote Mitochondrial Function. Journal of Cellular and Molecular Medicine. 2025;29(8). doi:10.1111/jcmm.70566

BibTeX
@article{Ren2025,
  author = {Ren, Ying-Jie and Sun, Tian-Qi and Lu, Yu and Liu, Dan-Li and Gao, Rui and Li, Ting and Guo, Min and Liu, Qing-Hua and Wang, Hai-Long and Pang, Min},
  title = {rhCC16 Suppresses Cellular Senescence and Ameliorates COPD‐Like Symptoms by Activating the AMPK/Sirt1‐PGC‐1‐α‐TFAM Pathway to Promote Mitochondrial Function},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  volume = {29},
  number = {8},
  doi = {10.1111/jcmm.70566}
}
Kostenlos starten →